💊
İlaç Sektörü Hisseleri
İlaç Sektörü altında 485 Hisse Senedi
İlaç sektöründe faaliyet gösteren ABD şirketlerinin hisse senetleri. Gerçek zamanlı fiyatlar, finansal analizler ve detaylı şirket bilgileri.
485
Toplam Hisse
$3.2T
Toplam Piyasa Değeri
İlaç Sektörü Hisseleri
Sayfa 2/5 (Toplam: 485)
| SEMBOL | ŞİRKET | PİYASA DEĞERİ | FİYAT | DEĞİŞİM | |
|---|---|---|---|---|---|
| JANX | Janux Therapeutics, Inc. | $1.38B | $23.80 | 1.00% | |
| OMCL | Omnicell, Inc. | $1.36B | $30.37 | 1.81% | |
| ANIP | ANI Pharmaceuticals, Inc. | $1.34B | $58.72 | 0.79% | |
| DYN | Dyne Therapeutics, Inc. | $1.34B | $11.96 | 2.29% | |
| CLDX | Celldex Therapeutics, Inc. | $1.31B | $19.78 | 0.30% | |
| SPRY | ARS Pharmaceuticals, Inc. | $1.19B | $14.43 | 6.84% | |
| ETNB | 89bio, Inc. | $1.16B | $9.84 | 0.31% | |
| PCRX | Pacira BioSciences, Inc. | $1.14B | $25.84 | 0.35% | |
| DVAX | Dynavax Technologies Corporation | $1.13B | $9.79 | 0.31% | |
| INVA | Innoviva, Inc. | $1.13B | $19.57 | 0.41% | |
| AMPH | Amphastar Pharmaceuticals, Inc. | $1.13B | $25.71 | 0.27% | |
| BLFS | BioLife Solutions, Inc. | $1.10B | $21.88 | 1.97% | |
| OCUL | Ocular Therapeutix, Inc. | $1.09B | $8.01 | 1.60% | |
| MDXG | MiMedx Group, Inc. | $1.02B | $6.43 | 1.83% | |
| OPK | OPKO Health, Inc. | $1.02B | $1.36 | 0.00% | |
| ELVN | Enliven Therapeutics, Inc. | $1.00B | $17.77 | 0.17% | |
| GYRE | Gyre Therapeutics, Inc. | $1.00B | $9.07 | 4.12% | |
| MLYS | Mineralys Therapeutics, Inc. | $991.97M | $15.58 | 0.51% | |
| COLL | Collegium Pharmaceutical, Inc. | $959.44M | $29.14 | 0.14% | |
| PAHC | Phibro Animal Health Corporation | $957.00M | $24.42 | 0.97% | |
| NVAX | Novavax, Inc. | $954.00M | $7.34 | 2.09% | |
| HROW | Harrow Health, Inc. | $942.45M | $28.11 | 3.35% | |
| RCUS | Arcus Biosciences, Inc. | $898.96M | $8.93 | 6.10% | |
| SYRE | Spyre Therapeutics, Inc. | $877.54M | $15.28 | 1.74% | |
| SNDX | Syndax Pharmaceuticals, Inc. | $820.03M | $10.54 | 0.75% | |
| ARDX | Ardelyx, Inc. | $811.07M | $3.67 | 8.93% | |
| NTLA | Intellia Therapeutics, Inc. | $802.25M | $6.87 | 7.79% | |
| CMRX | Chimerix, Inc. | $801.08M | $8.54 | 0.00% | |
| CRMD | CorMedix Inc. | $799.65M | $12.14 | 0.65% | |
| CDMO | Avid Bioservices, Inc. | $798.90M | $12.49 | 0.00% | |
| NAGE | Niagen Bioscience Inc | $795.18M | $10.82 | 0.00% | |
| GERN | Geron Corporation | $777.04M | $1.52 | 2.70% | |
| LENZ | LENZ Therapeutics, Inc. | $776.91M | $29.20 | 1.12% | |
| PRAX | Praxis Precision Medicines, Inc. | $741.64M | $38.55 | 0.26% | |
| NRIX | Nurix Therapeutics, Inc. | $727.67M | $10.63 | 0.09% | |
| NUVB | Nuvation Bio Inc. | $717.54M | $2.12 | 6.19% | |
| BCAX | Bicara Therapeutics Inc. Common Stock | $711.15M | $9.25 | 2.01% | |
| AVXL | Anavex Life Sciences Corp. | $693.22M | $7.53 | 1.31% | |
| EMBC | Embecta Corp. | $692.54M | $10.53 | 0.72% | |
| CURLF | Curaleaf Holdings, Inc. | $671.69M | $0.83 | 5.36% | |
| EOLS | Evolus, Inc. | $666.68M | $9.19 | 1.61% | |
| IMNM | Immunome, Inc. | $656.07M | $8.76 | 2.12% | |
| AKBA | Akebia Therapeutics, Inc. | $651.34M | $3.03 | 0.66% | |
| AVBP | ArriVent BioPharma, Inc. Common Stock | $650.26M | $21.25 | 1.19% | |
| RCKT | Rocket Pharmaceuticals, Inc. | $649.66M | $2.51 | 4.20% | |
| TRVI | Trevi Therapeutics, Inc. | $645.57M | $6.51 | 2.36% | |
| DAWN | Day One Biopharmaceuticals, Inc. | $635.03M | $6.38 | 1.54% | |
| ABUS | Arbutus Biopharma Corporation | $610.82M | $3.36 | 2.33% | |
| SLP | Simulations Plus, Inc. | $610.57M | $31.84 | 1.01% | |
| ANAB | AnaptysBio, Inc. | $602.89M | $22.23 | 1.46% | |
| IOVA | Iovance Biotherapeutics, Inc. | $564.35M | $1.75 | 4.37% | |
| COGT | Cogent Biosciences, Inc. | $563.59M | $5.44 | 1.27% | |
| KALV | KalVista Pharmaceuticals, Inc. | $561.29M | $11.80 | 0.76% | |
| OMI | Owens & Minor, Inc. | $544.73M | $6.60 | 1.54% | |
| RGLS | Regulus Therapeutics Inc. | $543.14M | $7.93 | 0.13% | |
| REPL | Replimune Group, Inc. | $541.80M | $8.98 | 4.16% | |
| KROS | Keros Therapeutics, Inc. | $539.78M | $14.15 | 0.93% | |
| SION | Sionna Therapeutics, Inc. | $539.20M | $13.69 | 2.98% | |
| TYRA | Tyra Biosciences, Inc. | $506.48M | $9.10 | 1.62% | |
| SVRA | Savara Inc. | $500.11M | $2.28 | 1.79% | |
| KURA | Kura Oncology, Inc. | $489.58M | $5.69 | 2.23% | |
| MNMD | Mind Medicine (MindMed) Inc. | $485.81M | $7.26 | 0.00% | |
| STOK | Stoke Therapeutics, Inc. | $481.00M | $9.54 | 1.95% | |
| RLAY | Relay Therapeutics, Inc. | $477.47M | $3.00 | 2.60% | |
| TSHA | Taysha Gene Therapies, Inc. | $472.65M | $2.71 | 1.45% | |
| ARVN | Arvinas, Inc. | $459.12M | $7.20 | 4.00% | |
| GPCR | Structure Therapeutics Inc. | $449.92M | $21.76 | 2.94% | |
| CGEM | Cullinan Oncology, Inc. | $449.69M | $8.64 | 0.40% | |
| ALT | Altimmune, Inc. | $443.60M | $5.43 | 3.21% | |
| LFMD | LifeMD, Inc. | $429.03M | $12.21 | 6.27% | |
| SIGA | SIGA Technologies, Inc. | $422.46M | $5.98 | 2.92% | |
| FTRE | Fortrea Holdings Inc. | $421.01M | $4.30 | 2.87% | |
| RGNX | REGENXBIO Inc. | $419.34M | $8.85 | 1.34% | |
| SAGE | Sage Therapeutics, Inc. | $402.34M | $6.46 | 0.92% | |
| PRTC | PureTech Health plc | $401.60M | $18.43 | 1.74% | |
| AMLX | Amylyx Pharmaceuticals, Inc. | $400.24M | $5.15 | 5.10% | |
| SRDX | Surmodics, Inc. | $399.09M | $29.02 | 1.73% | |
| ERAS | Erasca, Inc. | $396.60M | $1.40 | 3.11% | |
| SANA | Sana Biotechnology, Inc. | $395.85M | $2.17 | 4.41% | |
| ORGO | Organogenesis Holdings Inc. | $393.88M | $2.74 | 3.86% | |
| SEPN | Septerna, Inc. | $391.74M | $9.25 | 6.19% | |
| PGEN | Precigen, Inc. | $391.09M | $1.32 | 5.04% | |
| MAZE | Maze Therapeutics, Inc. | $389.35M | $10.01 | 17.75% | |
| TRML | Tourmaline Bio, Inc. | $389.18M | $16.68 | 1.03% | |
| EYPT | EyePoint Pharmaceuticals, Inc. | $389.10M | $7.24 | 0.42% | |
| ABSI | Absci Corporation | $377.54M | $2.65 | 3.28% | |
| MGTX | MeiraGTx Holdings plc | $369.44M | $5.12 | 4.48% | |
| TECX | Tectonic Therapeutic, Inc. | $368.88M | $21.51 | 3.97% | |
| ORIC | ORIC Pharmaceuticals, Inc. | $346.20M | $8.17 | 2.51% | |
| CYRX | Cryoport, Inc. | $342.69M | $6.01 | 1.01% | |
| MBX | MBX Biosciences, Inc. Common Stock | $340.09M | $12.42 | 2.36% | |
| BNTC | Benitec Biopharma Inc. | $336.70M | $15.36 | 1.48% | |
| CAPR | Capricor Therapeutics, Inc. | $333.44M | $9.89 | 1.98% | |
| RIGL | Rigel Pharmaceuticals, Inc. | $323.85M | $19.20 | 1.69% | |
| ARCT | Arcturus Therapeutics Holdings Inc. | $321.65M | $12.53 | 1.57% | |
| EBS | Emergent BioSolutions Inc. | $313.73M | $6.32 | 2.17% | |
| FULC | Fulcrum Therapeutics, Inc. | $305.52M | $6.88 | 2.76% | |
| TRDA | Entrada Therapeutics, Inc. | $304.77M | $7.60 | 3.80% | |
| HUMA | Humacyte, Inc. | $300.16M | $2.67 | 3.61% | |
| ATYR | aTyr Pharma, Inc. | $294.60M | $4.47 | 5.05% |